Orchid Chemicals And Pharmaceuticals

Stocks in news: Infosys, L&T, Wipro, Strides, Shree Renuka

Stocks in news: Hindalco, Praj, BoI, L&T Fin, Pfizer, Eros

Stocks in news: Infosys, BoB, Hero, Maruti, GMR, Zensar

Govt to commission study on impact of FDI in pharma

The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.

Orchid Chemical up 6%, mulls options to cut interest burden

The pharma company in its filing to exchange says it is currently in talks with banks to explore the possibility of converting its rupee debt into dollar denominated debt.

Orchid Chemicals in talks with banks for debt rejig

The company has a total debt of around Rs 3,100 crore. Set up in 1992 as an export-oriented unit, Orchid Chemicals & Pharmaceuticals currently has presence across segments such as anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products.

Stocks in news: Sun Pharma, DLF, Orchid Chem, Cairn, Natco

Nifty, Bank Nifty to make new lows in 1-2 wks: Ramakrishnan

According to Ramki Ramakrishnan of Al Ahli Bank of Kuwait this is a complex correction which is a bit difficult to trade. He thinks both the Nifty and Bank Nifty are likely to make new lows in coming week or two.

Orchid Chemicals & Pharma Q1 net loss at Rs 47.56 cr

The company had posted a net loss of Rs 60.14 crore for the corresponding period of the previous fiscal, Orchid Chemicals & Pharmaceuticals said in a filing to BSE.

Bull's Eye: Buy Hotel Leela, GMDC, Mindtree, sell OBC

Jay Thakkar of Sharekhan suggests buying Indraprastha Gas with a target of Rs 484.

Bull's Eye: Buy Ashoka Bulidcon, Dish TV, Arvind, Gati

Krish Subramanyam of Altamount Capital advises buying Orchid Chemicals with a target of Rs 67.

Buy HBL Power, Kesoram Ind, Orchid Chem: Krish Subramanyam

Krish Subramanyam of Altamount Capital recommends buying Orchid Chemicals for a target of Rs 65 and Aarti Industries.

Bull's Eye: Buy Dish TV, Orchid Chem, DHFL, GVK Power

Avinnash Gorakssakar of Precision Investment Services suggests buying Dish TV with a target of Rs 112.

Trending in trade: 4 hit & flop stocks as market surges

The Sensex was up 283.17 points or 1 percent at 27115.83, and the Nifty up 83.05 points or 1 percent at 8174.60. About 1634 shares advanced, 1099 shares declined, and 157 shares were unchanged.

Top buzzing midcap stocks to trade on June 18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Asian Paints, Himatsingka Seide, Orchid Chemicals, Strides Arcolab, Shasun Pharma, Cipla, Suzlon Energy, Ujaas Energy, Tech Mahindra and Eicher Motors.

Orchid Chemical up 16% on USFDA nod for anti-bacterial drug

"Orchid has received approval from the USFDA for the abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets (320 mg) with 180 days of generic drug exclusivity," said the drug maker in its filing.

Top 10 stocks laden with pharma: Strides, Glenmark in focus

While Strides and Shasun merger gets into trouble, Glenmark gets into a spot post plant inspection.

Stocks in news: Sun Pharma, Cipla, Orchid Chem, M&M, Bharti

Orchid Chemicals gets USFDA nod for anti-bacterial tablets

The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets in the strength of 320 mg, Orchid Chemicals & Pharmaceuticals said in a filing to BSE.

Orchid Chemicals gets USFDA nod for two generic drugs

The company has received approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for Rivastigmine capsules in 1.5 mg, 3 mg, 4.5 mg, 6 mg strengths and Felodipine extended - release tablets in 2.5 mg, 5 mg, 10 mg strengths, Orchid Chemicals & Pharmaceuticals said in a filing to the BSE.